Objective
This study seeks to quantify the relationship between anthropometrically-predicted visceral adipose tissue (apVAT) and all-cause and cause-specific mortality among individuals of European descent in a population-based prospective cohort study of 10,624 participants.
Methods
We predicted apVAT with a validated regression equation that included age, body mass index, and waist and thigh circumferences.
Results
During a median of 18.8 years, 3,531 participants died with 1,153 and 741 deaths attributable to cardiovascular disease and cancer, respectively. In multivariable-adjusted analyses that accounted for demographic, clinical, and behavioral characteristics, higher apVAT was associated with an increased risk of all-cause (Ptrend<0.001), cardiovascular-specific (Ptrend<0.001), and cancer-specific mortality (Ptrend=0.007). Excluding participants with a history of cancer, myocardial infarction, heart failure, or diabetes at baseline did not substantively alter effect estimates. apVAT more accurately predicted all-cause, cardiovascular-specific, and cancer-specific mortality than body mass index (P<0.001), waist circumference (P<0.001), or the combination of body mass index and waist circumference (P<0.001).
Conclusions
These data provide evidence that apVAT is associated with all-cause and cause-specific mortality in a large population-based sample of men and women of European descent. These results support the use of apVAT to risk-stratify individuals for premature mortality when imaging data are not available such as in routine clinical practice or in large clinical trials.